Pseudoephedrine hydrochloride

Phase 3Small molecule

GSK

Pseudoephedrine hydrochloride is one of 69 small molecule programs targeting Sinusitis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

SinusitisActive, not recruiting

Nasal CongestionActive, not recruiting

SinusitisPreclinical

Active, not recruiting

Nasal CongestionPhase 3

Active, not recruiting

Competition

Competitive Landscape

94 competitors in Sinusitis

#DrugCompanyPhaseTrials

Avelox

Bayer

Approved

2 2

Ketek

Sanofi

Approved

2 3

Nurtec

Cipro

Asmanex Hfa

1 6

Inomax

MMallinckrodt

Approved

—7

Sporanox

SSebela Pharmaceuticals Development LLC

Normodyne

Tobrex

VViatris Specialty LLC

Approved

—10

Brevibloc

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Sinusitis1 trial

Acupuncture and Herbal Treatment of Chronic HIV Sinusitis

Completed·IImmune Enhancement Project·N/A·NCT00002149·40 enrolled

Fasting Conditions1 trial

Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions

Completed·RRanbaxy Laboratories Limited·N/A·NCT00779831·36 enrolled

Nasal congestion1 trial

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Completed·PPerrigo Company·Phase 3·NCT01744106·565 enrolled

Infections1 trial

Preventing Frequent Sinus Infections in HIV-Infected Patients

Withdrawn·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00000752

MRI Scan1 trial

A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.

Completed· GSK logo

GSK··NCT00517946·21 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Pseudoephedrine hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pseudoephedrine hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pseudoephedrine hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: GSK

Pseudoephedrine hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Sinusitis1 trial

Fasting Conditions1 trial

Nasal congestion1 trial

Infections1 trial

MRI Scan1 trial

References

Drug Info

Quick Facts

Related News